SeQuent Scientific Limited is India’s largest and amongst the ‘Top 20’ global animal health companies, backed by global investment firm ‘The Carlyle Group’ as the promoter. The company has 8 manufacturing facilities across Europe, Turkey, Brazil & India with the Vizag site being India’s only USFDA approved dedicated veterinary API facility. SeQuent offers a comprehensive portfolio of finished drug formulations, active pharmaceutical ingredients along with analytical services, which address the needs of the global animal health sector.
Location: India, Maharashtra, Mumbai
Employees: 1001-5000
Founded date: 2002
Investors 1
| Date | Name | Website |
| - | The Carlyl... | carlyle.co... |
Mentions in press and media 2
| Date | Title | Description |
| 14.11.2024 | Carlyle hits the sell button on another Indian bet eyeing juicy returns | Pro Neeraj Bharadwaj, MD at Carlyle India, serves on the boards of several portfolio firms such as Hexaware, Indegene, Nxtra Data Centers, Piramal Pharma, Sequent Scientific, and Dailyhunt Private equity firm Carlyle, which logged partial e... |
| 27.09.2024 | Sequent Scientific and Viyash Lifesciences to merge, create differentiated animal healthcare company | Sequent Scientific Ltd and Viyash Lifesciences Private Limited are looking to merge, with the aim of creating a differentiated animal healthcare company with end-to-end capabilities, the two companies said, without divulging financial detai... |